Colorectal Cancer Screening and Diagnostic

Colorectal Cancer (Colon cancer)

Medicare covers one screening FOBT per year for beneficiaries ages 50 or older. The test must be ordered by the patient’s treating physician. Either a stool guaiac test or a FIT will be covered, but not both. Also, at least 11 months must have passed since the month of the patient’s last test.

Difference between screening and diagnostic colonoscopy

A screening test is a test provided to a patient in the absence of signs or symptoms. A screening colonoscopy is a service performed on an asymptomatic person for the purpose of testing for the presence of colorectal cancer or colorectal polyps.

Diagnostic colonoscopy is a test performed as a result of an abnormal finding, sign or symptom (such as abdominal pain, bleeding, diarrhea, etc.). Medicare and most payors do not waive the co-pay and deductible when the intent of the visit is to perform a diagnostic colonoscopy.

There are two Fecal Occult Blood Test (FOBT) tests:
Immunoassay test Chemical test
FIT (Fecal Immunochemical Test) FOBT (Fecal Occult Blood Test)
Diagnostic code 82274QW 82272
Screening code G0328QW – Medicare

82274 – Commercial

(Ages 50-75 years)

82270

 

(Ages 50-75 years)

Examples Hemosure – iFOB Test (FIT) HenrySchein – OneStep Occult Blood
Reimbursement ~$21 ~$4

 

Routine screening examinations:
ICD-10 Code Description
Z12.10 Encounter for screening for malignant neoplasm of intestinal tract, unspecified
Z12.11 Encounter for screening for malignant neoplasm of colon
Z12.12 Encounter for screening for malignant neoplasm of rectum
Diagnostic examinations

When billing for FOBT that is being performed because the patient has symptoms of a medical condition, use the medical diagnosis code that corresponds to the patient’s symptoms.